DXM + CBD-dominant products

https://dxm-atlas.org/en/interactions/cbd-dominant-products/

Compare

Key points for this combination

Direct measurements of how the body processes substances come from a specific study. That study did not find marked inhibition of the CYP2D6 enzyme [10].

General concepts in this text

Enzyme

A protein that helps chemical transformations in cells.

A transformation can build or break down a substance.

Sources: Enzyme

CYP2D6

One of the CYP enzymes involved in processing drugs.

Inhibition means reducing enzyme activity; it can change the processing of drugs.

Sources: CYP2D6

How well is this understood?

Mechanism confidence: medium

Confidence in the mechanism: medium

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method
Confidence in human DXM data: medium

Confidence in direct human evidence involving DXM: medium

M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.

Method
Measurements of drug concentration or metabolism.The study did not find the effect it tested for. Result in the interaction card

How to read ratings and study limits

How do the substances interact?

Can the amount reaching the body change?

Mechanism: CYP — CYP metabolism
ⓘ

CYP

A family of enzymes involved in chemically transforming drugs.

Metabolism can reduce or increase a substance’s activity.

Sources: CYP
  1. In a study of 18 healthy participants, a THC-dominant extract did not inhibit the CYP enzymes studied, whereas a CBD-rich extract inhibited several CYP enzymes but not CYP2D6. Finding below: Finding [10] · 1
  2. THC AUC increase versus THC-only product → The CBD-rich product also contained THC and increased THC AUC by 161% relative to the THC-only product, consistent with inhibition of oral THC clearance. Finding below: Finding [10] · 2

How can the effects add up?

Mechanism: CB — Cannabinoid-related effects
ⓘ

Cannabinoid-related effects / functional impairment and secondary physical hazards

What remains unknown?

A CBD-dominant product is not necessarily THC-free or free of other metabolic interactions. The negative CYP2D6 finding is specific to the studied formulation and endpoint [10].

Sources

Check the review’s wording

*Direct PK evidence limited to a specific study; marked CYP2D6 inhibition not found [10]

Combination row in the review: CYP — CYP metabolism; CB — Cannabinoid-related effects

Evidence and sources

Research publication

[10] · Evaluation of Cytochrome P450 Mediated Cannabinoid Drug Interactions in Healthy Adult Participants · 2023

Finding [10] · 1

What was found?

In a study of 18 healthy participants, a THC-dominant extract did not inhibit the CYP enzymes studied, whereas a CBD-rich extract inhibited several CYP enzymes but not CYP2D6.

Finding [10] · 2

What was found?

The CBD-rich product also contained THC and increased THC AUC by 161% relative to the THC-only product, consistent with inhibition of oral THC clearance.

What limits this finding?

A CBD-dominant product is not necessarily THC-free or free of other metabolic interactions. The negative CYP2D6 finding is specific to the studied formulation and endpoint [10].

Scientific review: Psychedelics and cannabinoids

Related entries

Reference

Open the source and related combinations →